The Siegel group

Venture Capital Active Boca Raton, United States Est. 1997
Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$500K
total disclosed, rounds participated
Stages

About

The Siegel Group is a U.S.-based business group engaged in securing private capital investment through venture capital firms, private equity funds, and angel investors. The company focuses on aligning businesses with appropriate sources of working capital to support expansion, product development, operational restructuring, management transitions, or ownership changes. Its approach relies on strategic connections and relationships with global private equity networks.

Portfolio · 1

Investment activity

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is The Siegel Group's primary focus?
The Siegel Group is a U.S.-based business group that focuses on securing private capital investment for businesses through venture capital firms, private equity funds, and angel investors. Their approach relies on strategic connections within global private equity networks.
When was The Siegel Group founded?
The Siegel Group was founded in 1997.
Who is a key member of The Siegel Group's team?
Ned L. Siegel serves as the President of The Siegel Group.
Which sector does The Siegel Group primarily invest in?
The Siegel Group has invested in the Health Tech & Life Sciences sector, as evidenced by their investment in Genesis Medical Vision.
Can you name a notable portfolio company of The Siegel Group?
Genesis Medical Vision, an AI platform for the early detection of cancer, is a portfolio company of The Siegel Group.
What was the funding stage and amount for The Siegel Group's investment in Genesis Medical Vision?
The Siegel Group participated in a Pre-Seed SAFE round for Genesis Medical Vision in July 2025, which raised $2.71M.
What is the typical investment range for The Siegel Group?
The Siegel Group's investment range is $500K.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)